InMode EmpowerRF (Morpheus8V)
RF Microneedling · Intravaginal + facial RF microneedling platform
Technology: RF Microneedling
Classification & configurations
Category group: Skin tightening & remodeling (RF microneedling, monopolar RF, HIFU)
At a glance
- New price
- $90k–$150kSource not documented
- Used asking price
- $50k–$80kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 3 FDA records
K192695 (Inmode MD, Ltd., 2019)
The InMode System with the Morpheus8 (Fractora) Applicators is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Morrpheus8 (Fractora) Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K200293 (InMode, Ltd., 2020)
The InMode System with the vTone Applicator is intended to provide electrical stimulation and neuromuscular re-education for the purpose of rehabilitation of weak pelvic floor muscles for the treatment of stress, urge, and mixed urinary incontinence in women.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K240017 (InMode, Ltd., 2024)
The InMode System with the Morpheus8 90 Applicator is intended for use in dermatological procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 90 Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 4, 2026 · How we verify
Axis runs $0–$150k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | InMode |
|---|---|
| Company | Owner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct |
| Parent company | InMode |
| Brand owner | InMode |
| Built by (OEM) | InMode Ltd. |
| Category | RF Microneedling |
| Technology | Intravaginal + facial RF microneedling platform |
| FDA status | FDA Cleared |
| 510(k) citation | K192695, K200293, K240017 |
| New price range | $90k–$150k |
| Used asking range | $50k–$80k |
| Consumables | Not published |
| Launch year | 2021 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Women's-health platform sharing Morpheus8 tech
How it worksTechnology and manufacturing
How the technology works
Three applicator families: Morpheus8V — fractional RF microneedling adapted for vaginal/vulvar tissue, coagulating and remodeling mucosal/submucosal tissue at depth. FormaV — non-ablative bipolar RF bulk heating of the vaginal canal and vulva with temperature feedback, aimed at circulation and laxity.
VTone — intravaginal EMS contracting and re-educating the pelvic floor for stress, urge, and mixed urinary incontinence. Together: tissue quality, laxity, and muscle function — the legitimate clinical trio behind the marketing gloss.
Patented technology
Morpheus8's Burst mode (multi-depth RF per insertion) carries to the V applicator; FormaV's ACE is thermistor cut-off control. The platform's edge is integration, not any single mechanism.
Origin
Yokneam, Israel (InMode).
FDA & regulatory detailClearance timeline, authorization route and citation notes
Clearance 2020 · Launch 2021 · K192695; K200293; K240017
FDA-cleared indications (verbatim)
K192695 (Inmode MD, Ltd., 2019)
The InMode System with the Morpheus8 (Fractora) Applicators is intended for use in Dermatologic and General Surgical procedures for Electrocoagulation and Hemostasis. At higher energy levels greater than 62 mJ/pin, use of the Morrpheus8 (Fractora) Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K200293 (InMode, Ltd., 2020)
The InMode System with the vTone Applicator is intended to provide electrical stimulation and neuromuscular re-education for the purpose of rehabilitation of weak pelvic floor muscles for the treatment of stress, urge, and mixed urinary incontinence in women.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K240017 (InMode, Ltd., 2024)
The InMode System with the Morpheus8 90 Applicator is intended for use in dermatological procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 90 Applicator is limited to Skin Types I-IV.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
RF Microneedling — Intravaginal + facial RF microneedling platform
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: InMode
Legal manufacturer: InMode Ltd. (Israel)
Applicant on the FDA record
Inmode MD, Ltd.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
FDA safety actions
Recorded recalls, warning letters and safety communications. Terminated actions remain visible as history.
How we report safety actionsChecked 7 Sep 2026 against FDA enforcement data dated 2 Sep 2026.
- FDA safety communicationFDA safety communication, issued 15 October 2025Open
Initiated Oct 15, 2025
Scope as FDA lists it
Applies to RF microneedling devices used for dermatologic or aesthetic procedures intended to improve the appearance of the skin. FDA is aware of reports of burns, scarring, fat loss, disfigurement and nerve damage, and of injuries needing surgical repair.
FDA advises providers to discuss these risks with patients and to report complications.
Reason and action
FDA advises providers to discuss these risks with patients before treatment, to use devices only as cleared, and to report complications to MedWatch. FDA did not name individual brands; the communication covers 510(k)-cleared RF microneedling devices as a class.
This communication applies to a class of devices, not to a specific unit or recall.
This is an FDA communication about a device class, not a recall of specific units; read the FDA notice for the reported risks and FDA's recommendations.
Manufacturer response: none on file — manufacturers can reply via their company profile.
FDA record
Look-alike devices
Comparing an unbranded RF microneedling unit? Check the exact model rather than relying on similar photos or treatment claims.
Listed manufacturer for this profile: InMode Ltd.
- FDA record: Match any claimed 510(k) or De Novo number to the exact model and applicant in the FDA database.
- Support: Get written warranty, training, consumables and service terms from the seller.
- Financing: Confirm availability for the exact unit before including it in your budget.
We do not profile these unbranded units or verify their support and financing terms. This profile’s FDA record applies to the named device, not every similar-looking unit.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published InMode EmpowerRF (Morpheus8V) data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Pregnancy, IUD in situ (protocol-dependent — verify), active pelvic infection or undiagnosed bleeding, pelvic mesh/implanted electronics, prolapse beyond mild grades, pending abnormal Pap workup.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History3 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 4, 2026
FDA indication
Source: Catalog update
September 4, 2026
FDA K-numbers
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "InMode EmpowerRF (Morpheus8V) — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.